Stock Track | BEAUTYFARM MED Plummets 10.62% Intraday on Investor Concerns Over Profit Sustainability After Strong Earnings

Stock Track
03/30

BEAUTYFARM MED's stock plummeted 10.62% during intraday trading on Monday, marking a significant downward movement for the healthcare company.

The sharp decline followed the release of the company's 2025 annual results, which showed strong financial performance with revenue increasing 16.7% year-on-year to approximately RMB 3 billion and adjusted net profit surging 41% to about RMB 381 million. Despite these positive figures, investors expressed concerns about whether the company can sustain this profit growth momentum going forward.

Chief Financial Officer Zhou Min addressed these concerns by stating that BEAUTYFARM MED expects to maintain profit growth through organic expansion and strategic acquisitions. The company plans to invest in brand development and digital transformation for 2026, using efficiency gains to fund future growth initiatives.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10